Literature DB >> 25420159

Fingolimod and risk of varicella-zoster virus infection: back to the future with an old infection and a new drug.

Kenneth L Tyler1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25420159     DOI: 10.1001/jamaneurol.2014.3390

Source DB:  PubMed          Journal:  JAMA Neurol        ISSN: 2168-6149            Impact factor:   18.302


× No keyword cloud information.
  6 in total

Review 1.  Infections in Patients Receiving Multiple Sclerosis Disease-Modifying Therapies.

Authors:  Elena Grebenciucova; Amy Pruitt
Journal:  Curr Neurol Neurosci Rep       Date:  2017-09-22       Impact factor: 5.081

2.  Safety of S1P Modulators in Patients with Immune-Mediated Diseases: A Systematic Review and Meta-Analysis.

Authors:  Juan S Lasa; Pablo A Olivera; Stefanos Bonovas; Silvio Danese; Laurent Peyrin-Biroulet
Journal:  Drug Saf       Date:  2021-03-05       Impact factor: 5.606

Review 3.  Clinical efficacy, safety, and tolerability of fingolimod for the treatment of relapsing-remitting multiple sclerosis.

Authors:  Alberto Gajofatto; Marco Turatti; Salvatore Monaco; Maria Donata Benedetti
Journal:  Drug Healthc Patient Saf       Date:  2015-12-11

4.  Adaptive Immune Responses in a Multiple Sclerosis Patient with Acute Varicella-Zoster Virus Reactivation during Treatment with Fingolimod.

Authors:  Andrea Harrer; Peter Wipfler; Georg Pilz; Katrin Oppermann; Elisabeth Haschke-Becher; Shahrzad Afazel; Jörg Kraus; Eugen Trinka; Johann Sellner
Journal:  Int J Mol Sci       Date:  2015-09-10       Impact factor: 5.923

5.  Increased Risk of Herpes Zoster Following Dermatomyositis and Polymyositis: A Nationwide Population-Based Cohort Study.

Authors:  Shin-Yi Tsai; Cheng-Li Lin; Ying-Chi Wong; Tse-Yen Yang; Chien-Feng Kuo; Jiung-Mou Cheng; Jyh-Seng Wang; Chia-Hung Kao
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.889

6.  Gender differences in safety issues during Fingolimod therapy: Evidence from a real-life Relapsing Multiple Sclerosis cohort.

Authors:  Alessia Manni; Vita Direnzo; Antonio Iaffaldano; Valentina Di Lecce; Carla Tortorella; Stefano Zoccolella; Pietro Iaffaldano; Maria Trojano; Damiano Paolicelli
Journal:  Brain Behav       Date:  2017-08-29       Impact factor: 2.708

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.